The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani
Authors:
Open Access
- 22 January 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 6 (3) , 515-528
Abstract
Available treatments for Chagas’ disease and visceral leishmaniasis are inadequate and there is a pressing need for new therapeutics. Drug discovery efforts for both diseases principally rely upon phenotypic screening. However, the optimisation of phenotypically-active compounds is hindered by a lack of information regarding their molecular target(s). To combat this issue we initiate target deconvolution studies at an early stage. Here, we describe comprehensive genetic and biochemical studies to determine the targets of three unrelated phenotypically-active compounds. All three structurally-diverse compounds target the Qi active-site of cytochrome b, part of the cytochrome bc1 complex of the electron transport chain. Our studies go on to identify the Qi site as a promiscuous drug target in Leishmania donovani and Trypanosoma cruzi with a propensity to rapidly mutate. Strategies to rapidly identify compounds acting via this mechanism are discussed to ensure drug discovery portfolios are not overwhelmed with inhibitors of a single target.Keywords
Funding Information
- Wellcome (092340, 105021)
This publication has 56 references indexed in Scilit:
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental dataBioinformatics, 2011
- Identification and Validation of Tetracyclic Benzothiazepines as Plasmodium falciparum Cytochrome bc1 InhibitorsChemistry & Biology, 2011
- A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing dataBioinformatics, 2011
- A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b InhibitorACS Chemical Biology, 2011
- Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasisBiochemical Pharmacology, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Jalview Version 2—a multiple sequence alignment editor and analysis workbenchBioinformatics, 2009
- T-coffee: a novel method for fast and accurate multiple sequence alignment 1 1Edited by J. ThorntonJournal of Molecular Biology, 2000
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993